PNC Financial Services Group’s Imunon IMNN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-1
Closed -$16 4754
2022
Q4
$16 Buy
+1
New +$19 ﹤0.01% 4746
2022
Q2
Sell
-256
Closed -$17K 4600
2022
Q1
$17K Hold
256
﹤0.01% 3648
2021
Q4
$27K Hold
256
﹤0.01% 3411
2021
Q3
$46K Hold
256
﹤0.01% 3111
2021
Q2
$64K Hold
256
﹤0.01% 2910
2021
Q1
$69K Hold
256
﹤0.01% 2793
2020
Q4
$36K Hold
256
﹤0.01% 3089
2020
Q3
$37K Buy
256
+232
+967% +$58.6K ﹤0.01% 2894
2020
Q2
$17K Buy
+24
New +$10.4K ﹤0.01% 3282

Other funds holding IMNN

PNC Financial Services Group's IMNN Position: Q1 2023 in Review

PNC Financial Services Group sold out of Imunon (IMNN) in Q1 2023, closing a stake of 1 share — an estimated $16 sold.

PNC Financial Services Group first reported a position in IMNN in Q2 2020 and held it in 9 quarters. The position peaked at $69K in Q1 2021. 18 funds tracked by Wall St. Rank hold IMNN as of Q1 2023.

  • PNC Financial Services Group reported no remaining Imunon position as of Q1 2023 after selling out during the quarter.
  • PNC Financial Services Group sold 1 Imunon share in Q1 2023, an estimated $16.
  • PNC Financial Services Group first reported a position in Imunon in Q2 2020 and held it in 9 quarters.
  • PNC Financial Services Group's Imunon position peaked at $69K in Q1 2021.
  • 18 funds tracked by Wall St. Rank held Imunon as of Q1 2023.

Based on PNC Financial Services Group's 13F filing for Q1 2023, filed 15 May 2023.